Skip to main content
. 2016 Aug 22;9(9):e39132. doi: 10.5812/jjm.39132

Table 3. Distribution of Co-Infections (n = 215).

Dual Infections (n=163) n n
IFV-A + HBoV 26 PIV + HCoV 3
IFV-A + IFV-B 20 IFV-B + HCoV 3
IFV-A + AdV 13 RSV A/B + PIV 2
IFV-B + MP 13 IFV-A + PIV 2
IFV-B + RV/EV 12 RV/EV + PIV 2
RV/EV + AdV 12 RSV A/B + HCoV 2
IFV-B + RSV A/B 10 IFV-A + LP 1
RV/EV + HMPV 9 IFV-A + BP 1
IFV-A + RSV A/B 5 IFV-A + MP 1
HBoV + RSV A/B 4 IFV-A + RV/EV 1
HBoV + MP 4 RSV A/B + CP 1
IFV-A + HCoV 4 RV/EV + HBoV 1
IFV-B + PIV 3 RV/EV + MP 1
PIV + MP 3 HMPV + HBoV 1
RSV A/B + LP 3
Triple infections (n = 49) n n
IFV-A + HBoV + MP 8 IFV-B + AdV + HCoV 5
IFV-B + RV/EV+ HCoV 8 RV/EV + HMPV + HBoV 4
RV/EV + AdV + HBoV 6 RV/EV + AdV + HMPV 4
RV/EV + HMPV + PIV 5 IFV-A + HBoV + HCoV 4
AdV + HCoV + BP 5
Quadruple infections (n = 3) n n
IFV-B + RV/EV + PIV+ MP 1 RV/EV + AdV + HBoV + HCoV 1
RV/EV + RSV A/B + HCoV + MP 1